Riskpilot← Back to searchSign inGet full accessFrojdocmedical AB
ABActiveOrg 5592159387Kapellgatan 5 FMedical specialists activities · NACE 8622Est. 20190 employees
Revenue 2024
SEK 62K
+9% vs 2023
EBITDA margin
-34.7%
-1979% vs 2023
Equity ratio
80.4%
Financial strength
Net profit 2024
SEK 19K
+632% vs 2023
| Revenue | SEK 62K | +9% |
| EBITDA | SEK -21K | -1979% |
| Net profit | SEK 19K | +632% |
| Total assets | SEK 225K | -2% |
| Equity | SEK 181K | +12% |
| Employees | 0 | — |
Legal name
Frojdocmedical AB
Org number
5592159387
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
26 augusti 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Medicinsk, idrottsmedicinsk och ortopedkirurgisk, handkirurgisk verksamhet. Fysioterapi och rehabilitering. Fastighetsutveckling och klockrenovering.
Address
Kapellgatan 5 F
Email
frojdocmedical@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 73 | 167 | 82 | 57 | 62 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 20 | 125 | 41 | −1 | −21 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 20 | 125 | 41 | −1 | −21 |
| Net financials | — | — | −0 | −0 | 6 |
| Profit before tax | 21 | 94 | 27 | 4 | 24 |
| Tax | −5 | −19 | −9 | −1 | −5 |
| Net profit | 16 | 75 | 18 | 3 | 19 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 147 | 252 | 266 | 230 | 225 |
| Equity | 66 | 141 | 160 | 162 | 181 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 81 | 80 | 63 | 29 | 44 |
| Total debt | 81 | 80 | 63 | 29 | 44 |
EBITDA margin
-34.7%
This company
15.8%
Market median
-320% vs market
20202024
Equity ratio
80.4%
This company
38.2%
Market median
+110% vs market
20202024
Return on equity
10.4%
This company
18.4%
Market median
+43% vs market
20202024
Net profit margin
30.6%
This company
8.1%
Market median
+278% vs market
20202024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Frojdocmedical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Fredrik Fröjd | Chairman | 0 companies |
| Karin Cecilia Fröjd | Board of Directors | 0 companies |
| Lars Gösta Fröjd | Deputy Board Member | 0 companies |